# Function-specific repetitive transcranial magnetic stimulation for fine motor rehabilitation in chronic stroke: a case report

**Authors:** Jia-Jia Qi, Hong Li, Kang-Jia Chen, Bing-Bing Zhou, Zu-Juan Ye, Qian Zhou, Jia-Hui Liu, Zhi-Yang Liu, Jue Wang

PMC · DOI: 10.1093/psyrad/kkaf033 · 2025-11-18

## TL;DR

A chronic stroke patient improved hand motor skills after a new type of brain stimulation guided by brain scans.

## Contribution

A novel function-specific rTMS approach guided by fMRI is proposed for fine motor rehabilitation in chronic stroke.

## Key findings

- A chronic stroke patient showed significant fine motor improvement after 8 weeks of function-specific rTMS.
- Electrophysiological and MRI data suggested restored interhemispheric functional balance.
- The intervention was effective even years after the initial stroke.

## Abstract

Although repetitive transcranial magnetic stimulation (rTMS) has been widely used in the treatment of post-stroke hemiparesis, its efficacy in restoring fine motor function of the hand remains limited, largely because of a lack of specificity in target selection. This study presents the case of a 61-year-old female chronic stroke patient who showed significant improvement in hand fine motor function following an 8-week intervention using function-specific rTMS guided by functional magnetic resonance imaging (fMRI). The patient previously experienced multiple lacunar infarctions in the bilateral basal ganglia and centrum semiovale and received the intervention 4 years after the stroke. Following treatment, substantial improvements were observed in fine motor function, with electrophysiological and MRI findings indicating a trend toward restored interhemispheric functional balance. This case highlights a novel therapeutic approach for patients who have shown limited responses to conventional rehabilitation.

## Linked entities

- **Diseases:** stroke (MONDO:0005098)

## Full-text entities

- **Diseases:** limb weakness (MESH:D018908), aphasia (MESH:D001037), cerebrovascular disease (MESH:D002561), hemiparesis (MESH:D010291), dysphagia (MESH:D003680), spasticity (MESH:D009128), hypertension (MESH:D006973), neurological deficits (MESH:D009461), motor dysfunction (MESH:D000068079), hand function impairment (MESH:D003072), lacunar infarctions (MESH:D059409), facial asymmetry (MESH:D005146), Stroke (MESH:D020521)
- **Chemicals:** ReHo (-), clopidogrel (MESH:D000077144), probucol (MESH:D011341), rosuvastatin (MESH:D000068718), aspirin (MESH:D001241), lipid (MESH:D008055), edaravone (MESH:D000077553)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12902691/full.md

---
Source: https://tomesphere.com/paper/PMC12902691